会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • IMPROVED THERAPEUTIC PROTOCOLS
    • 改进的治疗方案
    • WO2005016386A1
    • 2005-02-24
    • PCT/AU2004/001108
    • 2004-08-19
    • MEDITECH RESEARCH LIMITEDBROWN, TraceyBROWNLEE, GaryFOX, Richard
    • BROWN, TraceyBROWNLEE, GaryFOX, Richard
    • A61K47/36
    • A61K47/36A61K9/0014A61K9/0019A61K31/00
    • The present invention relates generally to therapeutic protocols to ameliorate infection by pathogenic agents. More particularly, the present invention relates to the use of hyaluronan (HA) or any of its chemical derivatives in conjunction with an anti-pathogenic agent to reduce its toxic effects and/or to target the anti-pathogenic agent to an infected cell which expresses HA-binding proteins including HA receptors. Even more particularly, HA is administered in conjunction with an anti-pathogenic agent to facilitate the prolonged administration of the agent, while reducing its toxic side affects and/or to facilitate targeted delivery of the anti-pathogenic agent. Owing to the protective effects of HA, the dose of anti-pathogenic agent may be substantially higher than a generally accepted effective dose, which would other wise cause unacceptable side effects in the subject.
    • 本发明一般涉及改善病原体感染的治疗方案。 更具体地说,本发明涉及透明质酸(HA)或其任何化学衍生物与抗病原体结合使用以降低其毒性作用和/或将抗病原体靶向感染细胞,其表达 HA结合蛋白包括HA受体。 甚至更具体地,HA与抗病原剂联合施用以促进药剂的延长施用,同时减少其毒副作用和/或促进抗病原体的靶向递送。 由于HA的保护作用,抗病原剂的剂量可能显着高于普遍接受的有效剂量,否则这将有助于造成受试者的不可接受的副作用。